Data on salmonellosis therapy detailed by researchers at University of Texas Medical Branch, Sealy Center for Vaccine Development

New research, 'An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth,' is the subject of a report. According to recent research from the United States, "An antitumor activity associated with several bacterial pathogens, including Salmonella enterica serovar Typhimurium, has been reported; however, the underlying immunological mechanism(s) that lead to an antitumor effect are currently unclear. Furthermore, such pathogens cannot be used to suppress tumor growth because of their potential for...

Want to see the full article?

• Purchase this article for only $3.00